PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6150639-7	1984	Marketed and investigational H2-antagonist drugs differ in their ability to inhibit drug metabolism due to the combined characteristics of cytochrome P-450 binding affinity and therapeutic dosage.	Hydrogen	29-31	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	139-155